Bridging Discoveries to Practice—CCO’s Conference to Clinic Highlights From the 2024 ASH Annual Meeting

Content Format:

Event

Date:

Jan 18, 2025

Credit Type:

AAPA | ACPE | AMA | ANCC

Credits:

1.00
Point-of-Care, Digital, Interactive Decision Support Tool (IDST) for the Prevention/Management of AEs During Treatment with BsAbs in MM

Content Format:

Tool

Date:

Jan 06, 2025

Credit Type:

--

Credits:

--
An Expert’s Guide to ASH 2024: Preview of the Top Abstracts

Content Format:

Conference Coverage

Date:

Dec 05, 2024

Credit Type:

--

Credits:

--
Key Insights on CD38 and BCMA as Targets for Therapy in Multiple Myeloma

Content Format:

Clinical Thought

Date:

Aug 28, 2024

Credit Type:

--

Credits:

--
Targeting CD38 and BCMA in Myeloma: Evidence and Enhanced Outcomes With Innovative Therapies

Content Format:

Video

Date:

Aug 09, 2024

Credit Type:

AMA

Credits:

1.50
Antibody–Drug Conjugates, Bispecific Antibodies and CAR T-Cell Therapies in Relapsed/Refractory Multiple Myeloma

Content Format:

Slideset

Date:

Jul 24, 2024

Credit Type:

--

Credits:

--
Critical Actions in Emergency Medicine: Timely Diagnosis and Treatment of CAR T-Cell‒ and Bispecific Antibody‒Related AEs in Multiple Myeloma

Content Format:

Slideset

Date:

Jan 19, 2024

Credit Type:

--

Credits:

--
Experts Answer Questions About Therapies Targeting BCMA and SLAMF7 in Multiple Myeloma

Content Format:

Clinical Thought

Date:

Jul 20, 2023

Credit Type:

--

Credits:

--
Immuno-Oncology in Myeloma: New Indications and Approvals

Content Format:

Slideset

Date:

Jun 01, 2023

Credit Type:

--

Credits:

--
An Update in Diagnosis, Prognosis, and Treatment of Multiple Myeloma – for the Treating Oncologist

Content Format:

Slideset

Date:

Jun 01, 2023

Credit Type:

--

Credits:

--
New Therapeutic Opportunities in Myeloma

Content Format:

Slideset

Date:

Jun 01, 2023

Credit Type:

--

Credits:

--